Evaluation of the effectiveness of differential target multiplexed spinal cord stimulation for treatment of Persistent Spinal Pain Syndrome Type II (PSPS-T2). Identification of clinical effective parameters concerning frequency, pulse duration, amplitude and battery consumption/recharge frequency and safety evaluation.
having chronic pain as a result of PSPS-T2 that exists for at least 6 months with at least moderate pain intensity (4 or higher measured on numeric rating scale (NRS) or 31mm or higher measured on visual analogue scale (VAS) for the dominant pain location.
being offered treatment with DTM SCS
being at least 18 years old
Expected inability of patients to properly operate the SCS system
History of coagulation disorders, lupus erythematosus, diabetic neuropathy
Active malignancy
Addiction to drugs and/or alcohol (more than 5 units /day)
Universitair Ziekenhuis Brussel
Lead sponsor